Topic New therapies in rheumatic diseases
REVIEW PAPER
Molecular mechanisms and potential applications of chondroitin sulphate in managing post-traumatic osteoarthritis
Iryna Golovach, Dmytro Rekalov, Oleh Ye Akimov, Heorhii Kostenko, Viktoriia Kostenko, Artur Mishchenko, Natalia Solovyova, Vitalii Kostenko
Reumatologia 2023;61(5):395–407
CASE-BASED REVIEW
Biological treatment in Felty's Syndrome with profound neutropenia
Reumatologia 2023;61(3):213–218
LETTER TO THE EDITOR
Successful use of tadalafil in oligohydramnios associated with lupus pregnancy
Reumatologia 2023;61(3):219–220
ORIGINAL PAPER
Radiosynovectomy of the hip joint – preliminary experience
Reumatologia 2023;61(3):186–190
ORIGINAL PAPER
The impact of intra-sacroiliac joint methylprednisolone injection in the recovery of patients with spondyloarthropathy: a randomized controlled trial
Reumatologia 2022;60(5):332–339
ORIGINAL PAPER
Effect of whole body cryotherapy on low back pain and release of endorphins and stress hormones in patients with lumbar spine osteoarthritis
Reumatologia 2022;60(4):247–251
ORIGINAL PAPER
Improvement of digestive symptoms in fibromyalgia patients following a diet modification according to histamine release test – an observational study
Reumatologia 2022;60(3):209–212
ORIGINAL PAPER
Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An observational study
Reumatologia 2022;60(2):81–91
ORIGINAL PAPER
The course of COVID-19 in patients with Behçet’s disease
Reumatologia 2021;59(6):356–361
CASE-BASED REVIEW
Is intra-articular infliximab therapy a good alternative to radionuclide synovectomy for a patient with refractory pigmented villonodular synovitis?
Reumatologia 2021;59(5):340–345
ORIGINAL PAPER
The use of radiosynovectomy in patients with juvenile idiopathic arthritis. Assessment of treatment efficacy and safety
Agnieszka Gazda, Jarosław Ćwikła, Beata Kołodziejczyk, Izabela Szczygielska, Elżbieta Hernik, Piotr Gietka, Lidia Rutkowska-Sak
Reumatologia 2021;59(4):219–229
REVIEW PAPER
Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
Reumatologia 2021;59(4):252–259
LETTER TO THE EDITOR
Brodalumab in the treatment of psoriatic arthritis – the latest reports
Reumatologia 2021;59(2):126–127
CASE-BASED REVIEW
Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
Reumatologia 2021;59(1):58–61
REVIEW PAPER
Baricitinib for the treatment of rheumatoid arthritis
Ivan Urits, Jacob Israel, Hayk Hakobyan, George Yusin, Grace Lassiter, Nathan Fackler, Amnon A. Berger, Hisham Kassem, Alan Kaye, Omar Viswanath
Reumatologia 2020;58(6):407–415
ORIGINAL PAPER
Investigation of anti-inflammatory effects of bee venom in experimentally induced adjuvant arthritis
Reumatologia 2020;58(5):265–271
REVIEW PAPER
Liver involvement in rheumatic diseases
Joanna Podgórska, Paulina Werel, Jakub Klapaczyński, Dorota Orzechowska, Mariusz Wudarski, Andrzej Gietka
Reumatologia 2020;58(5):289–296
REVIEW PAPER
Macrophagic myofasciitis: an atypical presentation for a rare disease with a challenging approach
Reumatologia 2020;58(3):167–172
REVIEW PAPER
Desensitization to biological agents used in rheumatology
Reumatologia 2020;58(1):26–33
REVIEW PAPER
The place of omega-3 and omega-6 acids in supplementary treatment of inflammatory joint diseases
Reumatologia 2020;58(1):34–41
REVIEW PAPER
Monogenic autoinflammatory diseases in adults – a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment
Reumatologia 2019;57(6):326–335
ORIGINAL PAPER
Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
Anna Felis-Giemza, Kornelia Chmurzyńska, Jolanta Nałęcz-Janik, Katarzyna Romanowska-Próchnicka, Katarzyna Świerkocka, Mariusz Wudarski, Marzena Olesińska
Reumatologia 2019;57(5):257–263
REVIEW PAPER
Systemic sclerosis – multidisciplinary disease: clinical features and treatment
Piotr Sobolewski, Maria Maślińska, Marta Wieczorek, Zuzanna Łagun, Aleksandra Malewska, Marek Roszkiewicz, Raman Nitskovich, Elżbieta Szymańska, Irena Walecka
Reumatologia 2019;57(4):221–233
REVIEW PAPER
Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy
Reumatologia 2019;57(4):214–220
REVIEW PAPER
Tildrakizumab in the treatment of psoriasis – literature review
Reumatologia 2019;57(4):234–238
REVIEW PAPER
Risankizumab in the treatment of psoriasis – literature review
Reumatologia 2019;57(3):158–162
ORIGINAL PAPER
Eosinophilic fasciitis (Shulman’s disease): review and comparative evaluation of seven patients
Reumatologia 2019;57(2):85–90
CASE REPORT
Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up
Katarzyna Pawlak-Buś, Wiktor Schmidt, Michał Olejarz, Anna Czyż, Mieczysław Komarnicki, Piotr Leszczyński
Reumatologia 2019;57(1):50–54
LETTER TO THE EDITOR
Comment on the article “Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology”
Reumatologia 2018;56(6):409
REVIEW PAPER
Hyperthermia in rheumatic diseases. A promising approach?
Reumatologia 2018;56(5):316–320
ORIGINAL PAPER
Tocilizumab in the treatment of systemic-onset juvenile idiopathic arthritis – single-centre experience
Reumatologia 2018;56(5):279–284
GUIDELINES
Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
Eugeniusz J. Kucharz, Marcin Stajszczyk, Anna Kotulska-Kucharz, Bogdan Batko, Marek Brzosko, Sławomir Jeka, Piotr Leszczyński, Maria Majdan, Marzena Olesińska, Włodzimierz Samborski, Piotr Wiland
Reumatologia 2018;56(4):203–211
ORIGINAL PAPER
Pharmacoeconomic evaluation of treatment effectiveness with selected biologic treatment in rheumatoid arthritis therapy
Reumatologia 2018;56(4):212–218
ORIGINAL PAPER
Factors of depression among patients with rheumatoid arthritis
Reumatologia 2018;56(4):219–227
REVIEW PAPER
Biosimilar switching – current state of knowledge
Piotr Wiland, Bogdan Batko, Marek Brzosko, Eugeniusz J. Kucharz, Włodzimierz Samborski, Jerzy Świerkot, Ewa Więsik-Szewczyk, Julia Feldman
Reumatologia 2018;56(4):234–242
REVIEW PAPER
Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion
Brygida Kwiatkowska, Maria Majdan, Agnieszka Mastalerz-Migas, Maciej Niewada, Barbara Skrzydło-Radomańska, Artur Mamcarz
Reumatologia 2017;55(6):290–297
CASE REPORT
A child with subcorneal pustular dermatosis responded to IVIG treatment (Sneddon-Wilkinson disease)
Reumatologia 2017;55(6):323–327
ORIGINAL PAPER
Diagnostic delays in rheumatic diseases with associated arthritis
Filip Raciborski, Anna Kłak, Brygida Kwiatkowska, Bogdan Batko, Małgorzata Sochocka-Bykowska, Aleksandra Zoń-Giebel, Zbigniew Gola, Zbigniew Guzera, Maria Maślińska, J. Grygielska, M. Mańczak, S. Ostrowska, P. Samel-Kowalik
Reumatologia 2017;55(4):169–176
REVIEW PAPER
The human body as an energetic hybrid? New perspectives for chronic disease treatment?
Reumatologia 2017;55(2):94–99
CASE REPORT
Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
Reumatologia 2016;54(6):321–325
ORIGINAL PAPER
Automated assessment of joint synovitis activity from medical ultrasound and power doppler examinations using image processing and machine learning methods
Reumatologia 2016;54(5):239–242
REVIEW PAPER
Radionuclide synovectomy – essentials for rheumatologists
Reumatologia 2016;54(3):108–116
REVIEW PAPER
Intestinal microbiota transplant – current state of knowledge
Reumatologia 2016;54(1):24–28
ORIGINAL PAPER
Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis
Zbigniew Żuber, Dorota Turowska-Heydel, Małgorzata Sobczyk, Marta Banach-Górnicka, Katarzyna Rusnak, Anna Piszczek, Elżbieta Mężyk
Reumatologia 2016;54(1):19–23
ORIGINAL PAPER
Efficacy of radiation synovectomy (radiosynovectomy or radiosynoviorthesis) with yttrium-90 in exudative inflammation of synovial membrane of knee joints in patients with rheumatic diseases – preliminary report
Joanna Zalewska, Małgorzata Węgierska, Tacjana Barczyńska, Marzena Waszczak, Paweł Żuchowski, Sławomir Jeka
Reumatologia 2016;54(1):3–9
CASE REPORT
Granulomatosis with polyangiitis – therapeutic challenge
Reumatologia 2015;53(6):345–351
REVIEW PAPER
The role of physiological elements in future therapies of rheumatoid arthritis. III. The role of the electromagnetic field in regulation of redox potential and life cycle of inflammatory cells*
Reumatologia 2015;53(4):219–224
Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome – effective treatment with tocilizumab
Reumatologia 2015;53(3):157–160
Mesenchymal stem cells – a new therapeutic option for rheumatic diseases?
Reumatologia 2015;53(1):1–2
The role of physiological elements in the future therapies of rheumatoid arthritis. II. The relevance of energy redistribution in the process of chronic inflammation
Reumatologia 2015;53(1):40–45
Influence of biologic therapy on growth in children with chronic inflammatory connective tissue diseases
Joanna Świdrowska, Agnieszka Zygmunt, Małgorzata Biernacka-Zielińska, Jerzy Stańczyk, Elżbieta Smolewska
Reumatologia 2015;53(1):14–20
ORIGINAL PAPER
The influence of vibroacoustic therapy on the functional status of patients with gonarthrosis. A preliminary report
Reumatologia 2014;52(5):292–298
REVIEW PAPER
Certolizumab pegol in the treatment of spondyloarthritis
Reumatologia 2014;52(4):263–268
REVIEW PAPER
Certolizumab pegol – new option in the treatment of psoriatic arthritis
Reumatologia 2014;52(3):181–188
CASE REPORT
Multifocal granulocellulare tumor of the skin in a patient with adult-onset Still’s disease treated with adalimumab
Reumatologia 2014;52(3):213–215
ORIGINAL PAPER
The use of intravenous immunoglobulin in pediatric rheumatology
Zbigniew Żuber, Marta Górnicka-Banach, Zofia Szymanowska, Dorota Turowska-Heydel, Małgorzata Sobczyk, Lidia Rutkowska-Sak
Reumatologia 2014;52(3):160–165
CASE REPORT
Heterotopic ossifications after two-stage septic revision knee arthroplasty in a rheumatoid arthritis patient
Reumatologia 2013;51(5):389–393
SHORT COMMUNICATION
Recommendations for diagnostic and therapeutic procedures in systemic onset juvenile idiopathic arthritis. The opinion of the Panel of Experts of the National Consultant in the field of rheumatology
Zbigniew Żuber, Lidia Rutkowska-Sak, Elżbieta Smolewska, Agnieszka Korobowicz-Markiewicz, Katarzyna Kobusińska, Bogna Dobrzyniecka, Iwona Klimecka, Witold Tłustochowicz
Reumatologia 2013;51(5):328–331
EDITORIAL ARTICLE
Epstein-Barr virus and autoimmunity: effective preventive and therapeutic strategies are urgently needed
Reumatologia 2023;61(5):327–330
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.